ClinicalTrials.govpublic full text
Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
healthy volunteers
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 175066
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.